Showing results (261-270 of 471) with videos related to

Sort By:
Pageof 48
Pediatric Pulmonology|January 27, 2006
Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in childrenKyung-Yil Lee, Hyung-Shin Lee, Ja-Hyun Hong, et al.
Journal of Paediatrics and Child Health|August 1, 2020
Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2Davinder Singh-Grewal, Ryan Lucas, Kristine McCarthy, et al.
Brain, Behavior, and Immunity|March 3, 2020
Experiences of racial discrimination and cardiometabolic risk among Australian childrenNaomi Priest, Mandy Truong, Shiau Chong, et al.
BMC Infectious Diseases|November 3, 2005
The changing epidemiology of pediatric aseptic meningitis in Daejeon, Korea from 1987 to 2003Kyung-Yil Lee, David Burgner, Hyung-Shin Lee, et al.
Advances in Life Course Research|January 18, 2023
Better together: Advancing life course research through multi-cohort analytic approachesMeredith O'Connor, Elizabeth Spry, George Patton, et al.
BMJ Open|March 4, 2026
Can topical coconut oil reduce late-onset sepsis in extremely preterm infants? A pragmatic cluster-randomised controlled trial protocolTobias Strunk, Jennifer Mountain, Adrienne Gordon, et al.
AIDS (London, England)|December 8, 2022
In-utero HIV exposure and cardiometabolic health among children 5-8 years: findings from a prospective birth cohort in South AfricaAngela M Bengtson, Jennifer Pellowski, Stephen McGarvey, et al.
European Journal of Applied Physiology|January 17, 2023
Exercise-induced responses in matrix metalloproteinases and osteopontin are not moderated by exercise format in males with overweight or obesityAaron Raman, Jeremiah J Peiffer, Gerard F Hoyne, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 5, 2023
Results of the ARROW survey of anti-reflux practice in the United Kingdom, , Robert Walker, et al.
BMC Pediatrics|June 3, 2016
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestationCarmel T Collins, Robert A Gibson, Maria Makrides, et al.
Pageof 48